This study is an investigation of the neurologic, immunologic, and rheumatologic markers of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). PANS is a condition characterized by the abrupt, dramatic onset of obsessive compulsive disorder (OCD) and/or eating restriction accompanied by equally abrupt and severe co-morbid neuropsychiatric symptoms, which include anxiety, emotional lability, depression, irritability, aggression, oppositionality, deterioration in school performance, behavioral (developmental) regression, sensory amplification, movement abnormalities, sleep disturbance, and urinary frequency. PANS is thought to be caused by infection, inflammation, or alternate triggers that is associated with a brain response that leads to these symptoms. The purpose of this study is to examine specific neurologic, immunologic, rheumatologic, and genomic, components in children with the acute-onset of psychiatric symptoms. This research may begin to uncover a much larger story of autoimmune processes that are involved in psychiatric disorders of childhood. By better understanding the etiologic components of psychiatric phenomenon, future treatments may be better targeted to underlying causes.
The investigators will recruit 500 children, 1-18 years old at onset with PANS/PANDAS. They will be treatment naive and within one month of onset/exacerbation. The 500 children with PANS will be gender- and age-matched to 100 healthy children, to allow examination of immunologic, neurologic, genomic, and behavioral differences between these two groups of children.
Study Type
OBSERVATIONAL
Enrollment
500
Stanford University
Palo Alto, California, United States
RECRUITINGCerebral blood flow
The investigators will report results of altered cerebral blood flow from patients with PANS.
Time frame: Through study completion, up to 12 years
EEG patterns
The investigators will report results of abnormal EEG patterns from patients with PANS. All data will be obtained through the review of medical records, which are created during the routine clinical care of patients.
Time frame: Through study completion, up to 12 years
Rapid Eye Movement (REM) motor disinhibition
The investigators will report results of REM motor disinhibition from polysomnography studies. All data will be obtained through the review of medical records, which are created during the routine clinical care of patients.
Time frame: Through study completion, up to 12 years
Global Impairment Scores
All data will be obtained through the review of medical records, which are created during the routine clinical care of patients.
Time frame: Every 2-4 weeks for up to 12 years
Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS)
All data will be obtained through the review of medical records, which are created during the routine clinical care of patients.
Time frame: Every 2-4 weeks for up to 12 years
Columbia Impairment Scale
All data will be obtained through the review of medical records, which are created during the routine clinical care of patients.
Time frame: Every 2-4 weeks for up to 12 years
Caregiver Burden Inventory
All data will be obtained through the review of medical records, which are created during the routine clinical care of patients.
Time frame: Every 2-4 weeks for up to 12 years
Neurological findings
The investigators will report data from neurological exam findings, including milk maid grip, chorea, choreiform movements of arms and legs, apraxia, overflow dystonia, truncal instability, piano-playing fingers, glabellar sign, etc. All data will be obtained through the review of medical records, which are created during the routine clinical care of patients. These results will be aggregated to report the number of participants with abnormal neurological findings.
Time frame: Every 2-4 weeks for up to 12 years
Ellen Spartz
CONTACT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.